| Name | CDK7-IN-5 |
|---|---|
| Synonyms | 2-Butenamide, 4-(dimethylamino)-N-[4-[[[2-[[[8-(1-methylethyl)-2-[(1-methyl-4-piperidinyl)oxy]pyrazolo[1,5-a]-1,3,5-triazin-4-yl]amino]methyl]phenyl]amino]methyl]phenyl]-, (2E) |
| Description | CDK7-IN-5 is a CDK7 inhibitor with an IC50 value <100 nM. CDK7-IN-5 has anticancer effects. (WO2015154022A1 (Compound 104))[1]. |
|---|---|
| Related Catalog | |
| Target |
CDK7:<100 nM (IC50) |
| In Vitro | CDK7-IN-5 (Comp 104; 72 hours) inhibits the proliferation of A673 cells with an IC50 <500 nM[1]. |
| References |
[1]. Jason J. MARINEAU, et al. Inhibitors of cyclin-dependent kinase 7 (cdk7). WO2015154022A1. |
| Molecular Formula | C34H45N9O2 |
|---|---|
| Molecular Weight | 611.78 |